Abstract
Neurodegenerative diseases including Alzheimers disease (AD) and Parkinsons disease (PD) afflict growing numbers of people but treatments are not available or ineffective. These diseases are characterized by the loss of specific neuronal populations, the accumulation of protein aggregates inside and sometimes outside neurons, and an activation of immune pathways in the brain. The causes of sporadic forms of AD or PD are not known but it has been postulated that reduced trophic support to neurons together with age dependent increases in cellular stress lead to chronic injury and ultimately the demise of neurons. TGF-βs are neuroprotective factors and organizers of injury responses and as such might have a role in neurodegenerative disease. We review here the evidence mostly from genetically manipulated mice that links the TGF-β signaling pathway to neuronal phenotypes and neurodegeneration. Although many of these mutant models did not produce overt CNS phenotypes or adult brain were not studied due to embryonic lethality, there is growing support for a role of TGF-β signaling in neuronal maintenance, function, and degeneration. Future studies will have to determine whether dysregulation of TGF-β signaling in neurodegenerative diseases is significant and whether this signaling pathway may even be a target for treatment.
Keywords: Transforming growth factor-β, signaling, Smad, neuroprotection, CNS, brain, neurodegeneration
Current Alzheimer Research
Title: A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models
Volume: 3 Issue: 5
Author(s): Ina Tesseur and Tony Wyss-Coray
Affiliation:
Keywords: Transforming growth factor-β, signaling, Smad, neuroprotection, CNS, brain, neurodegeneration
Abstract: Neurodegenerative diseases including Alzheimers disease (AD) and Parkinsons disease (PD) afflict growing numbers of people but treatments are not available or ineffective. These diseases are characterized by the loss of specific neuronal populations, the accumulation of protein aggregates inside and sometimes outside neurons, and an activation of immune pathways in the brain. The causes of sporadic forms of AD or PD are not known but it has been postulated that reduced trophic support to neurons together with age dependent increases in cellular stress lead to chronic injury and ultimately the demise of neurons. TGF-βs are neuroprotective factors and organizers of injury responses and as such might have a role in neurodegenerative disease. We review here the evidence mostly from genetically manipulated mice that links the TGF-β signaling pathway to neuronal phenotypes and neurodegeneration. Although many of these mutant models did not produce overt CNS phenotypes or adult brain were not studied due to embryonic lethality, there is growing support for a role of TGF-β signaling in neuronal maintenance, function, and degeneration. Future studies will have to determine whether dysregulation of TGF-β signaling in neurodegenerative diseases is significant and whether this signaling pathway may even be a target for treatment.
Export Options
About this article
Cite this article as:
Tesseur Ina and Wyss-Coray Tony, A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models, Current Alzheimer Research 2006; 3 (5) . https://dx.doi.org/10.2174/156720506779025297
DOI https://dx.doi.org/10.2174/156720506779025297 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Alzheimer's Disease Drug Development
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide. Despite decades of research, no cure or disease-modifying treatment is available yet. Therefore, the need for developing effective therapies to treat Alzheimer's disease is an urgent matter. This special issue aims to provide a comprehensive overview of ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer’s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Impact of Tracer Retention Levels on Visual Analysis of Cerebral [<sup>18</sup>F]- Florbetaben Pet Images
Current Radiopharmaceuticals Intracranial Aneurysms; In Need of Early Diagnostic and Treatment Using Bio- and Nanotechnology
Current Medicinal Chemistry Subcutaneous Cavernous Haemangioma in a Patient with Klippel-Trenaunay Syndrome: A Case Report
Current Medical Imaging Hemothorax
Current Respiratory Medicine Reviews The Fetal Cardiac Function
Current Cardiology Reviews Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging Ultrasound Diagnosis of Soft Tissue Vascular Malformations and Tumours
Current Medical Imaging Properties and Clinical Development of a Novel Coating Technology: The poly[bis(trifluoroethoxy)phosphazene]
Recent Patents on Drug Delivery & Formulation Mesenchymal Stromal Cells from Umbilical Cord Blood
Current Stem Cell Research & Therapy A Feature-Free 30-Disease Pathological Brain Detection System by Linear Regression Classifier
CNS & Neurological Disorders - Drug Targets Arthritis of the Hip Caused by Arteriovenous Malformations: A Case Report
Current Medical Imaging The Role of microRNA in Ischemic and Hemorrhagic Stroke
Current Drug Delivery Use of Contrast Echocardiography in Intensive Care and at the Emergency Room
Current Cardiology Reviews Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology Cocaine Dependence and Stroke: Pathogenesis and Management
Current Neurovascular Research Hereditary Haemorrhagic Telangiectasia: A Rare Disease As A Model for the Study of Human Atherosclerosis
Current Pharmaceutical Design Pathophysiology of the Vascular Wall and its Relevance for Cerebrovascular Disorders in Aged Rodents
Current Neurovascular Research Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews Vasculogenesis: Making Pipes for the Cardiovascular Plumbing
Current Angiogenesis (Discontinued) Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews